Injection to treat MS goes on the PBS New PBS listings include an injectable treatment for multiple sclerosis likely to benefit more than 30,000 Australians each year.
More deprescribing needed in antidepressant users: Study Long-term antidepressant use is rising, especially among young Australians. One expert says she’s ‘not surprised’.
WHO backs GLP-1 therapies for obesity Landmark new guidelines have endorsed Ozempic-like medicines as a long-term treatment of obesity in adults, alongside ‘intensive behavioural interventions’.
Call for ‘more innovation’ in syphilis testing Amid calls for greater use of rapid tests, one GP says while they are ‘part of the toolkit’, innovation is needed to improve access.
TGA issues weight-loss drug safety alerts Wegovy and Mounjaro are among the high-profile medicines with new product warnings, with the watchdog linking GLP-1 RAs to new side effects.
‘A long time coming’: TGA clamps down on vitamin B6 The changes will see a long list of products become pharmacist-only medicines from 2027 following a striking rise in adverse events.
Prescribing expansions ‘step in the wrong direction’ At a time when antimicrobial resistance is running rampant, the RACGP is calling out Australia’s ‘rapid expansion’ of prescribers.
New GP guidance for women with high breast density The guidance confirms patients with dense breasts will be advised to consult their GP to discuss breast cancer risk.
Australia set for world-first cervical cancer elimination Vaccination programs have played a key role, and GPs remain ‘instrumental’ in boosting screening rates to reach the 2035 target.
New guide to support safe antidepressant deprescribing The new addition to the RACGP’s First do no harm guide walks GPs through a best practice approach to deprescribing antidepressants.